Welcome to the e-CCO Library!

P504: Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Fumery, M.(1);Filippi, J.(2);Abitbol, V.(3);Biron, A.(4);Laharie, D.(5);Serrero, M.(6);Altwegg, R.(7);Bouhnik, Y.(8);Peyrinbiroulet, L.(9);Gilletta, C.(10);Roblin, X.(11);Pineton de Chambrun, G.(12);Vuitton, L.(13);Bourrier, A.(14);Nancey, S.(15);Gornet, J.M.(16);Nahon, S.(17);Bouguen, G.(18);Viennot, S.(19);Pariente, B.(20);Amiot, A.(21);
Created: Wednesday, 2 June 2021, 4:12 PM
P504: Guselkumab, an IL-23p19 subunit–specific monoclonal antibody, binds CD64+ myeloid cells and potently neutralises IL-23 produced from the same cells
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Atreya, R.(1)*;Abreu, M.T.(2);Krueger, J.G.(3);Eyerich, K.(4,5);Sachen, K.(6);Greving, C.(6);Hammaker, D.(6);Bao, P.(6);Lacy, E.(7);Sarabia, I.(6);Deming, J.(6);Elloso, M.M.(8);Ritchlin, C.(9);McInnes, I.B.(10);Allez, M.(11);Fourie, A.(6);
Created: Friday, 14 July 2023, 11:05 AM
P504: How acceptable is a ‘treat to target’ (T2T) approach to IBD patients in clinical remission?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Carbonell1, J. Kane1, M. Omer1, A. Odouri Ochieng1, M. Pinder1, R. McKay1, J. Hamlin1, C. Selinger*1

Created: Friday, 22 February 2019, 9:41 AM
P504: Prospective analysis of micronutrient status and disease course in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Brownson, E.(1);Saunders, J.(1);Gerasimidis, K.(2);Karafoulidou, Z.(2);Seenan, J.P.(1);Macdonald, J.(1);
Created: Friday, 11 February 2022, 3:56 PM
P504: Stability observations in tacrolimus suppositories
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Lie*1, E. Jansen2, P. Hoeben2, R. Zaal3, D. Hodes2, M. Rosman2, W. Loos2, J. van der Woude1

Created: Friday, 22 February 2019, 9:49 AM
P504: The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Sollelis1,2*, R. Minet Quinard3, G. Bouguen4, M. Goutte1,2, F. Goutorbe1,5, D. Bouvier3, B. Pereira6, G. Bommelaer1,2, A. Buisson1,2

Created: Thursday, 21 February 2019, 9:14 AM
P505 Different failure rates after non-medical switching of 744 patients from adalimumab originator to 2 different adalimumab biosimilars at Cambridge University Hospitals, UK: real-world experience
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Rosembert1, A. Malaviya2, J. How2, J. Tomlison3, F. Toh3, M. Roe1, A. Nightingale4, C. Garcia-Sueiro4, P. Herbert4, D. Jadon2, P. Norris3, J. Thomas3, J. Magsino4, A. Negoescu2, T. Raine4

Created: Thursday, 30 January 2020, 10:12 AM
P505: Early therapeutic drug monitoring after induction therapy with infliximab: correlation with intestinal ultrasound
Year: 2021
Source: ECCO'21 Virtual
Authors: Nascimento, C.(1);Morão, B.(1);Frias Gomes, C.(1);Cúrdia Gonçalves, T.(2);Castro, F.(2);Moreira, M.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P505: Efficacy of MMX-mesalamine monotherapy for maintenance of remission in ulcerative colitis patients after mucosal healing
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lopez-Diaz J., Ferreiro R., De la Iglesia D., Lorenzo A., Dominguez-Munoz J.E., Barreiro-de Acosta M.

Created: Wednesday, 20 February 2019, 10:36 AM
P505: Factors influencing outcomes from surgery for Crohn’s disease: A perspective from a district hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

A.R. Aspari*, N. Husain, P. Thomas

Created: Thursday, 21 February 2019, 9:14 AM
P505: Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn's disease: results from “long vedo” italian multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: MocciMD FRCP, G.(1)*;Maconi , G.(2);Onidi, F.M.(1);Cataletti, G.(2);Elisei , W.(3);Scaldaferri, F.(4);Lorenzetti , R.(5);Pagnini, C.(6);Scarcelli, A.(7);Graziani , M.G.(6);Di Paolo , M.C.(8);Pranzo, G.(9);Luppino, I.(9);Monterubbianesi, R.(10);Faggiani, R.(3);Ferronato, A.(11);Savarino, E.(12);Pica, R.(13);Cocco, A.(13);Rodino, S.(14); Sebkova, L.(15);Zampaletta, C.(16);Gaiani, F.(17);Fanigliulo, L.(18);Allegretta , L.(19);Cuomo, A.(20);Donnarumma, L.(21);Della Valle , N.(22);Forti, G.(23);Antonelli, E.(24);Bassotti , G.(24);Iannelli, C.(25);Aragona, G.(26);Lauria, A.(27);Piergallini, S.(28);Colucci, R.(29);Binaghi, L.(1);Meucci, C.(30);Papa, A.(4);Tursi, A.(31);
Created: Friday, 14 July 2023, 11:05 AM
P505: Real-world short-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA Registry
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Iborra*1, B. Beltrán1, A. Fernández2, A. Gutiérrez3, B. Antolín4, J. M. Huguet5, R. de Francisco6, O. Merino7, D. Carpio8, S. García López9, F. Mesonero10, M. Mínguez11, R. Ferreiro12, A. Y. Carbajo13, M. Rivero14, M. Chaparro15, M. C. Piñero-Pérez16, D. Monfort i Miquel17, L. Bujanda18, M. F. García-Sepulcre19, A. Martín-Cardona20, F. Cañete21, C. Taxonera22, M. Sierra-Ausin23, J. Á. Ferrer-Rosique24, M. D. Martín-Arranz25, C. González-Muñosa26, N. Manceñido-Marcos27, I. Rodríguez-Lago28, E. Iglesias-Flores29, A. Forés-Bosch30, M. Navarro-Llavat31, M. Calafat32, R. E. Madrigal-Domínguez33, L. Ramos34, M. Arroyo35, D. Busquets36, R. Lorente37, E. Saiz-Arnau38, A. Hernández-Camba39, V. Jair-Morales40, C. Paredes41, M. Van Domselaar42, D. Hervás43, A. Cañada-Martínez43, P. Nos43

Created: Friday, 22 February 2019, 9:41 AM
P505: Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: TheodorakiMD- MA- PhD c, E.(1);Orfanoudaki, E.(2);Foteinogiannopoulou, K.(2);Koutroubakis, I.(2);
Created: Friday, 11 February 2022, 3:56 PM
P505: The effect of using a question prompt list in outpatient clinic consultations in a Dutch inflammatory bowel disease population
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Peek-Kuijt*1, M. de Jong1, N. Srivastava2, R. Veenendaal1, P. Maljaars1, L. van Bodegom-Vos3, A. Linn4, A. van der Meulen-de Jong1

Created: Friday, 22 February 2019, 9:49 AM
P506 Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Yanai1,2, S. Amir2, I. Avni Biron1,2, T. Tsadok Perets1,2, R. Shamir2,3, I. Dotan1,2, A. Assa2,3

Created: Thursday, 30 January 2020, 10:12 AM
P506: Endoscopic and clinical outcomes of upadacitinib in patients with moderate to severe Crohn's disease by baseline disease severity
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Siegmund, B.(1)*;Patel, K.(2);Torres, E.A.(3);Lakatos, P.L.(4,5);Seidelin, J.(6);Fleisher, M.(7);Ford, S.(8);Remple, V.(8);Lacerda, A.P.(8);Anyanwu, S.(8);Garrison, A.(8);Panés, J.(9);
Created: Friday, 14 July 2023, 11:05 AM
P506: Incidence risk of colorectal cancer, non-melanoma skin cancers and non-Hodgkin lymphoma in Japanese patients with ulcerative colitis based on large-scale claims database
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Kobayashi1*, A. Uda2, T. Mineyama2, E. Udagawa2, K. Iwasaki3, W. Tang3, T. Hibi1

Created: Thursday, 21 February 2019, 9:14 AM
P506: Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vegni E.1, Gilardi D.2, Corrò B.E.3, Menichetti J.4, Leone D.1, Allocca M.2, Bonovas S.5, Furfaro F.2, Danese S.2,6, Fiorino G.*7

Created: Wednesday, 20 February 2019, 10:36 AM
P506: Rates of clinical remission among patients with Ulcerative Colitis from real-world clinical practice settings from Germany
Year: 2022
Source: ECCO'22
Authors: Bokemeyer, B.(1);Picker, N.(2);Kromer, D.(2);Rosin, L.(3);Patel, H.(4);
Created: Friday, 11 February 2022, 3:56 PM
P506: Serum infliximab and antibodies to infliximab levels in Crohn’s disease and ulcerative colitis patients on long-term maintenance therapy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Waterman*1, H. Bar Yoseph1, B. Ungar2, S. Ben - Horin2, Y. Chowers1

Created: Friday, 22 February 2019, 9:49 AM